Related Experiment Video
Updated: Jul 2, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Effects of Internet-Based Lifestyle Interventions on Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized
Chengjie Wang1, Yilong Song1, Jingjing Wu1
1Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China, shutcm.edu.cn.
Objective:
This study aimed to evaluate the efficacy of internet-based interventions in improving clinical outcomes among patients with nonalcoholic fatty liver disease (NAFLD) and to synthesize evidence for future research directions.
Methods:
A comprehensive search of nine electronic databases (CNKI, Wanfang, VIP, CBM, PubMed, Web of Science, Cochrane Library, Embase, and CINAHL) was conducted from inception to September 23, 2024, to identify randomized controlled trials (RCTs) assessing internet-based lifestyle interventions in NAFLD patients. Two independent researchers screened studies, extracted data, and evaluated methodological quality. Meta-analyses were performed using RevMan 5.3.5 software.
Results:
Ten RCTs involving 714 participants were included. Compared to the control group, the intervention groups showed significant reductions in BMI, ALT and AST. Weight loss trended toward reduction but was not statistically significant, though subgroup analysis showed significant weight loss in interventions lasting > 3 months.
Conclusion:
Internet-based interventions significantly improve BMI and liver enzymes in NAFLD patients, with prolonged interventions (> 3 months) enhancing weight loss. Digital platforms show promise for enhancing self-management, though standardized long-term trials are needed to optimize efficacy.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Atherosclerosis III: Management